ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Quantum BioPharma Ltd. (QNTM) shows an Average True Range (ATR) of 3.01 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 266.91K, indicating liquidity. These fundamental metrics provide insight into QNTM's underlying financial health and market activity.
Quantum BioPharma Ltd. (QNTM) technical indicators as of August 11, 2025: the SMA 20 is 22.53%, SMA 50 at 38.44%, and SMA 200 at 197.27%. The RSI 14 value is 64.22, suggesting its current momentum. These technical analysis signals help assess QNTM's price trends and potential future movements.
Quantum BioPharma Ltd. (QNTM) stock performance overview as of August 11, 2025: The 52-week high is $38.25 (currently -23.63% below), and the 52-week low is $2.7 (currently 981.85% above). Over the past year, QNTM's performance is 468.29%, compared to the S&P 500's 20.13% change.
According to market data, Quantum BioPharma Ltd. (QNTM) stock's recent performance metrics show that over the last month, QNTM is 54.39%, with a Year-to-Date (YTD) performance of 693.75%. Over the past year, the stock has seen a 468.29% change. These figures summarize QNTM's price movements across various periods, reflecting its historical returns.
According to current financial data, QNTM stock's P/E (TTM) ratio is -1.59, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for QNTM, including P/S (N/A), P/B (5.79), and P/FCF (-10.93), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.